Universiti Malaya (UM) has formalised a Memorandum of Agreement (MOA) with SATEERA® Sdn Bhd in a ceremony witnessed by Chang Lih Kang, Malaysia’s Minister of Science, Technology and Innovation (MOSTI). The agreement signals Malaysia’s continued progress in translating university-originated research into commercially applied biotechnology, reinforcing the role of academia–industry collaboration in advancing national innovation capacity.
The technology underpinning SATEERA® was originally developed within UM’s research ecosystem more than a decade ago, progressing through laboratory refinement, patent development and industry translation before forming the foundation of the BioNexus-status biotechnology company. With this formal collaboration, both parties commit to advancing scientific validation and expanding research into selective anti-infective mechanisms, strengthening the bridge between academic research and real-world application.
At the core of SATEERA®’s innovation is its Natural Smart Anti-Infective Technology, designed to selectively inhibit harmful bacteria while preserving beneficial microbial communities. Unlike conventional broad-spectrum antimicrobial formulations that eliminate bacteria indiscriminately, this targeted approach focuses on microbial modulation. As global research increasingly highlights concerns around antimicrobial resistance and the importance of maintaining healthy microbiomes, selective anti-infective strategies are gaining relevance within hygiene science and applied biotechnology.
The innovation has already progressed beyond laboratory validation into commercial application through REDFORES®, SATEERA®’s intimate care brand and the first to integrate its patented technology into women’s hygiene solutions. Under the partnership, REDFORES® products will undergo further scientific evaluation with UM’s academic team, reinforcing a commitment to evidence-based development in women’s intimate health. The company’s technology has also previously undergone independent validation by Universiti Teknologi Malaysia (UTM) and SGS Malaysia, and SATEERA® currently holds 14 international patents across Asia.
Speaking at the ceremony, Chang Lih Kang emphasised the importance of translating research into real-world solutions, noting that innovation must move beyond the laboratory to strengthen national capability and improve quality of life in line with Malaysia’s broader biotechnology aspirations. SATEERA® co-founders Datuk Wira Calvin Khiu and Datuk Wira Jment Lim underscored the need to rethink conventional hygiene paradigms, shifting away from indiscriminate eradication models toward smarter, microbiome-conscious approaches grounded in scientific validation and long-term well-being.
The event also included recognition by ASEAN and ASIA Records and featured an interdisciplinary panel discussion themed “Leading the Good Bacteria Era: Redefining Global Hygiene Standards.” Academics and medical specialists explored the broader implications of microbiome preservation and selective anti-infective science, particularly in the context of women’s intimate health. The collaboration is expected to expand validation studies and deepen research engagement within Malaysia’s biotechnology ecosystem, further positioning the country as a producer of advanced, science-driven health solutions.
